WuXi AppTec (OTCMKTS:WUXIF – Get Free Report) is anticipated to post its resultson Tuesday, March 24th. Analysts expect WuXi AppTec to post earnings of $0.3831 per share and revenue of $1.7675 billion for the quarter.
WuXi AppTec Price Performance
Shares of WuXi AppTec stock opened at $13.88 on Tuesday. The company has a fifty day moving average of $14.10 and a 200-day moving average of $14.41. WuXi AppTec has a 52-week low of $13.54 and a 52-week high of $16.80.
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides end-to-end solutions spanning discovery biology, medicinal chemistry, preclinical safety assessment, clinical trial support, and large-scale manufacturing of small molecules, biologics and advanced therapies. By integrating scientific expertise with state-of-the-art laboratory and production facilities, WuXi AppTec enables clients to accelerate the development of new treatments while managing time and cost pressures.
Key service offerings include custom synthesis and process research for active pharmaceutical ingredients (APIs), biologics development and manufacturing, cell line development, gene therapy support, as well as comprehensive analytical and testing services.
Further Reading
- Five stocks we like better than WuXi AppTec
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
